Endocrinology and diabetology in 2025 made a decisive shift beyond glucose-centric care toward integrated cardiometabolic management. Dual incretin therapies such as tirzepatide strengthened long-term glycaemic and weight control, while late-stage data for oral GLP-1 receptor agonists signalled a potential shift away from injectable-only incretin t
394 Reached
Pancytopenia, a rare presentation of hyperthyroidism
832 Reached2 Comments
Complicated case of Osteoarthritis
1850 Reached2 Comments3 Likes
Vildagliptin in Reducing Risk of Post-partum Diabetes
2386 Reached7 Comments4 Likes
Managing Amenorrhea in Adolescent girl
2554 Reached5 Comments4 Likes
Link between PCOS, Obesity and Diabetes
479 Reached2 Likes